Improving Transplant Recipient Outcomes

Eurofins Transplant Genomics is committed to improving organ transplant outcomes with noninvasive diagnostics guided by genetic biomarkers.

Our Molecular Diagnostic Tests

Eurofins Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy.

Kidney


Surveillance for Subclinical Acute Rejection

kidneys-outline-73

Liver


Immunosuppression Optimization

kidneys-outline-73

Biomarker Science

Kidney

For kidney transplantation, doctors assess blood type compatibility and tissue matches. They perform tests to check for underlying health issues that might affect the success of the transplant. Since people with two healthy kidneys can live with one, living donors can be considered in addition to deceased donors. Doctors evaluate living donors’ health and compatibility during the pre-transplant process.

3d kidney rendering

Liver

For liver transplantation, doctors study a patient’s liver disease severity, overall health, and potential for complications. They conduct blood tests, imaging scans, and assessments of liver function. The patient’s position on the waiting list is determined by a scoring system, which considers factors like urgency and severity. Like kidney transplants, liver transplants can be performed with organs from living donors.

liver 3d rendering

How Can We Help

Surveillance for Subclinical Acute Rejection

Resources